186 related articles for article (PubMed ID: 24025145)
21. Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy.
Rice BA; Ver Hoeve ES; DeLuca AN; Esserman LJ; Rugo HS; Melisko ME
Breast Cancer Res Treat; 2018 Jan; 167(1):117-122. PubMed ID: 28921303
[TBL] [Abstract][Full Text] [Related]
22. The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review.
Marks DH; Okhovat JP; Hagigeorges D; Manatis-Lornell AJ; Isakoff SJ; Lacouture ME; Senna MM
Breast Cancer Res Treat; 2019 Jun; 175(2):267-276. PubMed ID: 30806923
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
Cigler T; Isseroff D; Fiederlein B; Schneider S; Chuang E; Vahdat L; Moore A
Clin Breast Cancer; 2015 Oct; 15(5):332-4. PubMed ID: 25749072
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review.
Lemieux J; Maunsell E; Provencher L
Psychooncology; 2008 Apr; 17(4):317-28. PubMed ID: 17721909
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy and Safety of Scalp Cooling Device RV21-01 for Suppression of Chemotherapy-Induced Alopecia in Breast Cancer Patients].
Nomizu T; Ueo H; Kato M; Fukuma E
Gan To Kagaku Ryoho; 2023 Mar; 50(3):321-325. PubMed ID: 36927900
[TBL] [Abstract][Full Text] [Related]
26. Does Scalp Cooling Have the Same Efficacy in Black Patients Receiving Chemotherapy for Breast Cancer?
Dilawari A; Gallagher C; Alintah P; Chitalia A; Tiwari S; Paxman R; Adams-Campbell L; Dash C
Oncologist; 2021 Apr; 26(4):292-e548. PubMed ID: 33512741
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of scalp cooling system in preventing chemotherapy induced alopecia - A single center prospective study.
Kate S; Patil R; Pathan D; Vyavhare R; Joseph S; Baby V; Ramesh YV; Nagarkar R
Cancer Treat Res Commun; 2021; 26():100280. PubMed ID: 33338853
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy.
Leandro-García LJ; Inglada-Pérez L; Pita G; Hjerpe E; Leskelä S; Jara C; Mielgo X; González-Neira A; Robledo M; Avall-Lundqvist E; Gréen H; Rodríguez-Antona C
J Med Genet; 2013 Sep; 50(9):599-605. PubMed ID: 23776197
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors.
Ingle JN; Schaid DJ; Goss PE; Liu M; Mushiroda T; Chapman JA; Kubo M; Jenkins GD; Batzler A; Shepherd L; Pater J; Wang L; Ellis MJ; Stearns V; Rohrer DC; Goetz MP; Pritchard KI; Flockhart DA; Nakamura Y; Weinshilboum RM
J Clin Oncol; 2010 Nov; 28(31):4674-82. PubMed ID: 20876420
[TBL] [Abstract][Full Text] [Related]
30. Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia.
Belum VR; de Barros Silva G; Laloni MT; Ciccolini K; Goldfarb SB; Norton L; Sklarin NT; Lacouture ME
Breast Cancer Res Treat; 2016 Jun; 157(2):395-400. PubMed ID: 27146710
[TBL] [Abstract][Full Text] [Related]
31. A Chinese version of the chemotherapy-induced alopecia distress scale based on reliability and validity assessment in breast cancer patients.
Cong W; Wu Y; Liu L; Hu M; Zhou C
Support Care Cancer; 2020 Sep; 28(9):4327-4336. PubMed ID: 31912364
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy-induced irreversible alopecia in early breast cancer patients.
Kim GM; Kim S; Park HS; Kim JY; Nam S; Park S; Kim SI; Kim D; Sohn J
Breast Cancer Res Treat; 2017 Jun; 163(3):527-533. PubMed ID: 28324267
[TBL] [Abstract][Full Text] [Related]
33. The Role of Hair Loss in Cancer Identity: Perceptions of Chemotherapy-Induced Alopecia Among Women Treated for Early-Stage Breast Cancer or Ductal Carcinoma in Situ.
Trusson D; Pilnick A
Cancer Nurs; 2017; 40(2):E9-E16. PubMed ID: 27070222
[TBL] [Abstract][Full Text] [Related]
34. Permanent Alopecia in Breast Cancer Patients: Role of Taxanes and Endocrine Therapies.
Slaught C; Roman M; Yashar S; Holland V; Goh C
Cutis; 2021 Mar; 107(3):E17-E22. PubMed ID: 33956617
[TBL] [Abstract][Full Text] [Related]
35. [Scalp cooling for the prevention of chemotherapy-induced alopecia: systematic review and meta-analysis.].
Trujillo-Martín MM; de Armas-Castellano A; González-Hernández Y; González-Pacheco H; Infante-Ventura D; Del Pino-Sedeño T; Ramallo-Fariña Y; Abt-Sack A; Rueda Domínguez A; Serrano-Aguilar P
Rev Esp Salud Publica; 2023 Mar; 97():. PubMed ID: 36999663
[TBL] [Abstract][Full Text] [Related]
36. Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.
Patel A; Kalachand R; Busschots S; Doherty B; Kapros E; Lawlor D; Hall N; Stordal BK
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD008766. PubMed ID: 35866378
[TBL] [Abstract][Full Text] [Related]
37. Patient-reported outcome assessment and objective evaluation of chemotherapy-induced alopecia.
Komen MMC; van den Hurk CJG; Nortier JWR; van der Ploeg T; Smorenburg CH; van der Hoeven JJM
Eur J Oncol Nurs; 2018 Apr; 33():49-55. PubMed ID: 29551177
[TBL] [Abstract][Full Text] [Related]
38. The effect of a helmet type, home-use low-level light therapy device for chemotherapy-induced alopecia: study protocol for a randomized controlled trial.
Wu CX; Li CH; Shiao YH; Cheng HY; Wu TH; Lee CH; Chang ZY; Yeh YC
Trials; 2023 Dec; 24(1):789. PubMed ID: 38053197
[TBL] [Abstract][Full Text] [Related]
39. A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia.
Lacouture ME; Dion H; Ravipaty S; Jimenez JJ; Thapa K; Grund EM; Benaim E; Tanna N; Luan S; DiTommaso N; Narain NR; Sarangarajan R; Granger E; Berman B; Goldfarb SB
Breast Cancer Res Treat; 2021 Feb; 186(1):107-114. PubMed ID: 33206291
[TBL] [Abstract][Full Text] [Related]
40. Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy.
Ohsumi S; Kiyoto S; Takahashi M; Hara F; Takashima S; Aogi K; Matsuda M; Yamamura N; Doi M
Support Care Cancer; 2021 Jan; 29(1):437-443. PubMed ID: 32388615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
